Don't miss out on the latest buzz around Emcure Pharmaceuticals IPO! Get ready to dive into the details and make informed decisions.
Emcure Pharmaceuticals has been making headlines with its IPO subscription process, raising a whopping ₹582 crore from anchor investors. The price range for the shares has been set at an enticing ₹960-1008 per share, sparking interest among potential investors. As the IPO subscription status reached 75%, employees and non-institutional investors led the charge, showing remarkable early enthusiasm.
With the IPO open for public subscription from July 3 to July 5, investors are buzzing with excitement over the opportunity to invest in Emcure Pharmaceuticals. The subscription reaching 1.32 times of the offered shares is a testament to the strong interest in the market.
Emcure Pharma IPO has gained considerable attention with a robust response on the first day. The IPO is set to remain open for investment until July 5, providing investors with ample time to make their decisions. As the IPO subscription status continues to trend positively, experts recommend considering a long-term investment approach with Emcure Pharmaceuticals Ltd for potential growth.
In the grey market, Emcure Pharma IPO is trading at a premium of ₹325, indicating high investor confidence in the company's future performance. The IPO pricing range of ₹960-1008 per share presents an attractive opportunity for retail investors to participate in the growing pharma sector.
Emcure Pharmaceuticals IPO subscription opens with ₹582 crore raised from anchor investors. Price range set at ₹960-1008 per share.
Emcure Pharma IPO subscription status Day 1: Till 2:00 PM, Emcure Pharma IPO was subscribed 75 per cent, led by employees and non-institutional investors.
The price band for Emcure Pharma IPO is set at Rs 960 to Rs 1008 per share, and will be open for public subscription from July 3 to July 5.
The offer received bids for 1.80 crore shares as against 1.37 lakh shares on offer.
Emcure Pharma IPO subscription status day 1: निवेशकों के पास इस आईपीओ में 5 जुलाई तक निवेश का मौका रहेगा। कंपनी का इरादा पब्लिक इश्यू के ...
Motilal Oswal, has come out with its report on Emcure Pharmaceuticalss Ltd. The research firm has recommended to “ Subscribe- Long Term” the ipo in its ...
आज से Emcure Pharma का IPO खुल गया है। आपको बता दें कि यह आईपीओ 5 जुलाई तक खुला रहेगा और इसकी लिस्टिंग 10 जुलाई को होगी।
Emcure Pharma IPO GMP: ग्रे मार्केट में एमक्योर फार्मा का आईपीओ 325 रुपये के प्रीमियम पर ट्रेड कर रहा है. निवेशकों को शानदार लिस्टिंग गेन ...
एमक्योर फार्मा आईपीओ प्राइस बैंड 960-1008 रुपये प्रति शेयर तय किया गया है. न्यूनतम लॉट साइज 14 शेयरों का है.
Emcure Pharmaceuticals has launched its IPO valued at ₹1952.03 crores. The IPO, which opened for subscription on July 3, 2024, and will close on July 5, ...
Emcure Pharmaceuticals initial public offerings (IPO), which opened for subscription on Wednesday, was fully subscribed by the later half of the first day ...
Retail investors can buy a minimum of 1 lot (14 shares) at Rs 14112, or 14 lots (196 shares) at Rs 1,97586. 50% of the issue has been allotted for QIBs ...
According to BSE data, the initial share sale attracted bids for 1,80,40960 shares, with 1,37,03538 shares on offer.
Emcure Pharmaceuticals IPO GMP: Shares of the company are available at a premium of ₹333 in the grey market today, say market observers.
Emcure Pharmaceuticals' public issue saw a strong start on its second day of bidding on July 4, driven by non-institutional and retail investors.
Emcure Pharma IPO: Unlisted shares of Emcure Pharma Ltd are trading Rs 330 higher in the grey market, signalling a 32.74 per cent listing gain from the ...
The Pune-based Emcure Pharma is selling its shares in the price band of Rs 960-1008 apiece. Investors can apply for a minimum of 14 shares and its multiples ...